Oncology Account Executive at BillionToOne

Spokane, Washington, United States

Apply Now

Not SpecifiedCompensation

Mid-level (3 to 4 years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, Healthcare, OncologyIndustries

Requirements

Bachelor's Degree or equivalent experience
Demonstrated successful sales track record (e.g., Presidents club, Chairman's club, Rookie of the Year, or a history of success - at or above goal for multiple quarters/years)
Experience selling to medical providers
Experience selling medical diagnostics, medical or surgical devices
Lives within the defined territory and centrally located to defined accounts
Commitment to travel within defined territory
Excellent organizational and communication skills (written and verbal) with demonstrated ability to effectively present to both internal and external customers
Effective time management skills required with a demonstrated ability to assess and prioritize opportunity required
Exceptionally bright, flexible, self-motivated and results oriented

Responsibilities

Increasing revenue and driving market development through direct sales to individual Oncologists
Creating and implementing a strategic business plan to grow revenue quickly in your geography
Sales efforts include effective prospecting and cultivating new business and maintaining key relationships

Skills

Account Management

Sales

Oncology

Molecular Diagnostics

Liquid Biopsy

Healthcare Sales

BillionToOne

Molecular diagnostics for prenatal and oncology testing

About BillionToOne

BillionToOne specializes in molecular diagnostics within the healthcare sector, focusing on prenatal screening and oncology testing. Their proprietary QCT technology allows for the detection and quantification of diseases at a single base-pair resolution, enabling the identification of minute variations in DNA. The company offers two main products: Northstar Select™, which helps determine the best initial therapy for patients, and Northstar Response™, which tracks the effectiveness of that therapy. Unlike many competitors, BillionToOne emphasizes accuracy, efficiency, and accessibility in molecular testing, providing diagnostic services directly to healthcare providers. Their goal is to positively impact healthcare by making molecular testing more reliable and available to everyone.

Menlo Park, CaliforniaHeadquarters

2016Year Founded

$380.2MTotal Funding

SERIES_DCompany Stage

Biotechnology, HealthcareIndustries

201-500Employees

Benefits

Competitive pay

Retirement savings package

Parental leave

Free snacks & lunches

Medical, dental, & vision premiums

On campus perks

Free-on-site EV charging

Risks

Emerging biotech startups could threaten BillionToOne's market share.

Rapid technological advancements may render their current technology obsolete.

Expansion into new facilities may face operational challenges or delays.

Differentiation

BillionToOne's QCT technology detects DNA variations at single base-pair resolution.

Their UNITY Fetal Antigen NIPT is the first US cfDNA test for fetal antigen genotyping.

They replace invasive amniocentesis with a safe, affordable blood test for prenatal screening.

Upsides

BillionToOne achieved a billion-dollar valuation with a $130 million funding round.

Their new Austin facility will create 1,000 jobs, boosting production and local economy.

Recognition as Diagnostics Company of the Year highlights their industry leadership.

Land your dream remote job 3x faster with AI

Try Jobo Free